-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Gaetan Michel PhD
Chief Operating Officer
Gaetan is the Chief Operating Officer and has been a valued member of the Volition team since 2014.
Gaetan is the Chief Operating Officer and has been a valued member of the Volition team since 2014 serving firstly as Chief Operating Officer of Belgian Volition and latterly as Chief Executive Officer of Belgian Volition.
With over 15 years’ project management, manufacturing and operational experience, Gaetan is ideally placed to oversee and expand Volition’s global operations including our innovation lab in San Diego, the manufacturing facility “Silver One” and Research & Development Facility in Belgium.
“Together the people at Volition create a unique environment that thrives on the desire to change the outlook for cancer patients throughout the world. The dynamism, enthusiasm and passion which exist will enable the company to make developments which will ultimately save lives.”
Gaetan Michel
Chief Operating Officer